DD200404A5 - Verfahren zur herstellung eines synergistisch wirkenden mittels - Google Patents

Verfahren zur herstellung eines synergistisch wirkenden mittels Download PDF

Info

Publication number
DD200404A5
DD200404A5 DD81232586A DD23258681A DD200404A5 DD 200404 A5 DD200404 A5 DD 200404A5 DD 81232586 A DD81232586 A DD 81232586A DD 23258681 A DD23258681 A DD 23258681A DD 200404 A5 DD200404 A5 DD 200404A5
Authority
DD
German Democratic Republic
Prior art keywords
fluoromethylhistidine
cimetidine
item
methyl
gastric
Prior art date
Application number
DD81232586A
Other languages
German (de)
English (en)
Inventor
Janos Kollonitsch
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DD200404A5 publication Critical patent/DD200404A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD81232586A 1980-08-18 1981-08-13 Verfahren zur herstellung eines synergistisch wirkenden mittels DD200404A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17935880A 1980-08-18 1980-08-18

Publications (1)

Publication Number Publication Date
DD200404A5 true DD200404A5 (de) 1983-05-04

Family

ID=22656255

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81232586A DD200404A5 (de) 1980-08-18 1981-08-13 Verfahren zur herstellung eines synergistisch wirkenden mittels

Country Status (8)

Country Link
EP (1) EP0046290B1 (ja)
JP (1) JPS5759812A (ja)
AU (1) AU7398381A (ja)
DD (1) DD200404A5 (ja)
DE (1) DE3168036D1 (ja)
FI (1) FI812469L (ja)
GR (1) GR74627B (ja)
PT (1) PT73517B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447443A (en) * 1982-11-15 1984-05-08 Merck & Co., Inc. Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID)
US5030645A (en) * 1990-10-15 1991-07-09 Merck & Co., Inc. Method of treating asthma using (S)-α-fluoromethyl-histidine and esters thereof
FR2822709B1 (fr) * 2001-03-30 2007-01-19 Antialis Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
FR2896156A1 (fr) * 2006-01-17 2007-07-20 Gaetan Terrasse Nouvelle utilisation de la tritoqualine en association avec des substances medicamenteuses antagonistes du recepteur h2 a l'histamine,pour le traitement des maladies inflammatoires digestives
EP2170317A4 (en) * 2007-02-12 2011-03-23 Mike Nicolaou TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), GASTRO-OESOPHAGEAL REFLUX DISEASE (GERD), FOOD ALLERGIES, AND OTHER DISEASES AND GASTROINTESTIN DISORDERS AFFECTED BY APPROPRIATE MANAGEMENT OF HISTAMINE USING A COMBINATION OF INHIBITORS HISTIDINE DECARBOXYLASE, MEDICAMEN

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000302A (en) * 1972-04-20 1976-12-28 Smith Kline & French Laboratories Limited Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors
US4215221A (en) * 1977-06-01 1980-07-29 Merck & Co., Inc. Fluorination process

Also Published As

Publication number Publication date
JPH0154326B2 (ja) 1989-11-17
PT73517B (en) 1983-07-06
AU7398381A (en) 1982-02-25
EP0046290A1 (en) 1982-02-24
JPS5759812A (en) 1982-04-10
PT73517A (en) 1981-09-01
EP0046290B1 (en) 1985-01-02
GR74627B (ja) 1984-06-29
FI812469L (fi) 1982-02-19
DE3168036D1 (en) 1985-02-14

Similar Documents

Publication Publication Date Title
DD202001A5 (de) Verfahren zur herstellung von aminoaethanolen
DE2558501C2 (ja)
DE1795792A1 (de) Die serumlipoidkonzentration vermindernde arzneimittel
DE2305092C2 (ja)
DE2713389C2 (ja)
DE2549783A1 (de) Triglyceride mit entzuendungshemmender wirkung
DD144763A5 (de) Verfahren zur herstellung von phenethanolaminen
DE69908421T2 (de) Pharmazeutische zusammensetzung enthaltend eine kombination der dextro- und laevo-isomeren von sotalol
DE2439859A1 (de) Verfahren zur herstellung von 3-(3,4dihydroxy-phenyl)-serin
DE1815808C3 (de) 1 -(Alkanoylaminophenoxy)-3-alkylamino-2-propanole, deren Herstellungsverfahren und pharmazeutische Zusammensetzungen auf deren Basis
DE3443065C2 (ja)
EP0086416A2 (de) Corynanthein-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DD200404A5 (de) Verfahren zur herstellung eines synergistisch wirkenden mittels
DE3320394A1 (de) Optisch aktive n-arylierte oxazolidinon-(2)-derivate, deren verwendung als spezifische und reversible inhibitoren von monoaminooxydase des b-typs sowie verfahren zu deren herstellung
EP1317430B1 (de) (2-azabicyclo [2.2.1]hept-7-yl)methanol-derivate als nikotinische acetylcholinrezeptor agonisten
DE2928594C2 (de) 3-Hydroxy-4-(hydroxymethyl)-benzoesäure, deren Salze, Hydrate und Hydratsalze, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2632118C3 (de) Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel
DE3804936A1 (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
DE1915230B2 (de) Hydroxyphenylalkylaminderivate, verfahren zu deren herstellung und arzneimittel auf deren basis
LU86397A1 (ja)
DE3839659A1 (de) Verwendung von benzomorphanen zur zytoprotektion
DD144764A5 (de) Verfahren zur herstellung von r-n-(2-phenyl-2-hydroxyethyl)-3-phenylpropylaminen
DE2911377C3 (de) 3-Hydroxy-4-hydroxymethyl-phenylglycin (Forphenicinol), dessen Hydrate und Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2003353C3 (de) Phenylisopropylaminoäthanol-Derivate, deren Herstellungsverfahren und Arzneimittel auf deren Basis
CH624397A5 (ja)

Legal Events

Date Code Title Description
A5 Published as prov. exclusive patent